{"entity":{"type":"insider","cik":"0001464907","url":"/insider/0001464907","json_url":"/insider/0001464907.json","name":"Ramos Eleanor","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":11,"n_filings":8,"first":"2010-02-26","last":"2021-12-06","span_basis":"filed_date"},"name_variants":[{"name":"Ramos Eleanor","source":"filing","n_filings":8,"first_seen":"2010-02-26","last_seen":"2021-12-06"}],"transactions":[{"id":5152810,"accession":"0001493152-21-030639","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-21-030639","line_url":"/filing/0001493152-21-030639#line-1","is_derivative":false,"issuer_cik":"0001464907","issuer_name":"Provention Bio, Inc.","issuer_ticker":"PRVB","issuer_name_source":null,"issuer_url":"/issuer/0001464907","owner_cik":"0001464907","owner_name":"Ramos Eleanor","owner_url":"/insider/0001464907","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5201.0,"shares_display":"5,201","price_per_share":6.492,"price_display":"6.49","price_state":"stated","total_value":33764.892,"total_display":"33,764.89","shares_owned_after":70000.0,"shares_owned_after_display":"70,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-03","filed_date":"2021-12-06","scope":"insider"},{"id":3223299,"accession":"0001493152-20-017180","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-20-017180","line_url":"/filing/0001493152-20-017180#line-1","is_derivative":false,"issuer_cik":"0001464907","issuer_name":"Provention Bio, Inc.","issuer_ticker":"PRVB","issuer_name_source":null,"issuer_url":"/issuer/0001464907","owner_cik":"0001464907","owner_name":"Ramos Eleanor","owner_url":"/insider/0001464907","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":299.0,"shares_display":"299","price_per_share":12.06,"price_display":"12.06","price_state":"stated","total_value":3605.94,"total_display":"3,605.94","shares_owned_after":64799.0,"shares_owned_after_display":"64,799","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-02","filed_date":"2020-09-02","scope":"insider"},{"id":3339022,"accession":"0001493152-20-016458","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-20-016458","line_url":"/filing/0001493152-20-016458#line-1","is_derivative":false,"issuer_cik":"0001464907","issuer_name":"Provention Bio, Inc.","issuer_ticker":"PRVB","issuer_name_source":null,"issuer_url":"/issuer/0001464907","owner_cik":"0001464907","owner_name":"Ramos Eleanor","owner_url":"/insider/0001464907","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":13.23,"price_display":"13.23","price_state":"stated","total_value":33075.0,"total_display":"33,075.00","shares_owned_after":64500.0,"shares_owned_after_display":"64,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-20","filed_date":"2020-08-20","scope":"insider"},{"id":7937054,"accession":"0001493152-19-019733","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-19-019733","line_url":"/filing/0001493152-19-019733#line-1","is_derivative":false,"issuer_cik":"0001464907","issuer_name":"Provention Bio, Inc.","issuer_ticker":"PRVB","issuer_name_source":null,"issuer_url":"/issuer/0001464907","owner_cik":"0001464907","owner_name":"Ramos Eleanor","owner_url":"/insider/0001464907","role":"Officer (CMO & COO)","officer_title":"CMO & COO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":14.34,"price_display":"14.34","price_state":"stated","total_value":28680.0,"total_display":"28,680.00","shares_owned_after":62000.0,"shares_owned_after_display":"62,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-26","filed_date":"2019-12-26","scope":"insider"},{"id":6704124,"accession":"0001493152-18-010232","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-18-010232","line_url":"/filing/0001493152-18-010232#line-1","is_derivative":false,"issuer_cik":"0001464907","issuer_name":"Provention Bio, Inc.","issuer_ticker":"PRVB","issuer_name_source":null,"issuer_url":"/issuer/0001464907","owner_cik":"0001464907","owner_name":"Ramos Eleanor","owner_url":"/insider/0001464907","role":"Officer (Chief Medical Officer & COO)","officer_title":"Chief Medical Officer & COO","security_title":"Common Stock, par value $0.0001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":60000.0,"shares_display":"60,000","price_per_share":4.0,"price_display":"4.00","price_state":"stated","total_value":240000.0,"total_display":"240,000.00","shares_owned_after":60000.0,"shares_owned_after_display":"60,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-19","filed_date":"2018-07-19","scope":"insider"},{"id":9204389,"accession":"0000899243-16-011349","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-16-011349","line_url":"/filing/0000899243-16-011349#line-2","is_derivative":false,"issuer_cik":"0001629137","issuer_name":"Global Blood Therapeutics, Inc.","issuer_ticker":"GBT","issuer_name_source":null,"issuer_url":"/issuer/0001629137","owner_cik":"0001464907","owner_name":"Ramos Eleanor","owner_url":"/insider/0001464907","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":30.28,"price_display":"30.28","price_state":"stated","total_value":30280.0,"total_display":"30,280.00","shares_owned_after":11000.0,"shares_owned_after_display":"11,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-12-22","filed_date":"2016-01-07","scope":"insider"},{"id":8482387,"accession":"0000899243-15-010395","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-15-010395","line_url":"/filing/0000899243-15-010395#line-2","is_derivative":false,"issuer_cik":"0001464907","issuer_name":"Global Blood Therapeutics, Inc.","issuer_ticker":"GBT","issuer_name_source":null,"issuer_url":"/issuer/0001464907","owner_cik":"0001464907","owner_name":"Ramos Eleanor","owner_url":"/insider/0001464907","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":30.28,"price_display":"30.28","price_state":"stated","total_value":30280.0,"total_display":"30,280.00","shares_owned_after":11000.0,"shares_owned_after_display":"11,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-12-22","filed_date":"2015-12-23","scope":"insider"},{"id":9204388,"accession":"0000899243-16-011349","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-16-011349","line_url":"/filing/0000899243-16-011349#line-1","is_derivative":false,"issuer_cik":"0001629137","issuer_name":"Global Blood Therapeutics, Inc.","issuer_ticker":"GBT","issuer_name_source":null,"issuer_url":"/issuer/0001629137","owner_cik":"0001464907","owner_name":"Ramos Eleanor","owner_url":"/insider/0001464907","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":200000.0,"total_display":"200,000.00","shares_owned_after":10000.0,"shares_owned_after_display":"10,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-17","filed_date":"2016-01-07","scope":"insider"},{"id":9204387,"accession":"0000899243-16-011349","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-16-011349","line_url":"/filing/0000899243-16-011349#line-3","is_derivative":false,"issuer_cik":"0001629137","issuer_name":"Global Blood Therapeutics, Inc.","issuer_ticker":"GBT","issuer_name_source":null,"issuer_url":"/issuer/0001629137","owner_cik":"0001464907","owner_name":"Ramos Eleanor","owner_url":"/insider/0001464907","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":20000.0,"total_display":"20,000.00","shares_owned_after":1000.0,"shares_owned_after_display":"1,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-08-17","filed_date":"2016-01-07","scope":"insider"},{"id":8482382,"accession":"0000899243-15-010395","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-15-010395","line_url":"/filing/0000899243-15-010395#line-1","is_derivative":false,"issuer_cik":"0001464907","issuer_name":"Global Blood Therapeutics, Inc.","issuer_ticker":"GBT","issuer_name_source":null,"issuer_url":"/issuer/0001464907","owner_cik":"0001464907","owner_name":"Ramos Eleanor","owner_url":"/insider/0001464907","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":200000.0,"total_display":"200,000.00","shares_owned_after":10000.0,"shares_owned_after_display":"10,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-17","filed_date":"2015-12-23","scope":"insider"},{"id":7290655,"accession":"0001209191-10-012588","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-10-012588","line_url":"/filing/0001209191-10-012588#line-1","is_derivative":false,"issuer_cik":"0001129425","issuer_name":"ZYMOGENETICS INC","issuer_ticker":"ZGEN","issuer_name_source":null,"issuer_url":"/issuer/0001129425","owner_cik":"0001464907","owner_name":"Ramos Eleanor","owner_url":"/insider/0001464907","role":"Officer (Sr. VP, Chief Medical Officer)","officer_title":"Sr. VP, Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":662.0,"shares_display":"662","price_per_share":5.66,"price_display":"5.66","price_state":"stated","total_value":3746.92,"total_display":"3,746.92","shares_owned_after":6099.0,"shares_owned_after_display":"6,099","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-02-24","filed_date":"2010-02-26","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":11,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":10,"open_market":true},{"code":"S","label":"Open-market sale","n":1,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":11},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001695357","name":"Provention Bio, Inc.","url":"/issuer/0001695357","role":"Officer (Chief Medical Officer)","n_filings":5,"first_seen":"2018-07-19","last_seen":"2021-12-06"},{"type":"issuer","type_label":"ISSUER","cik":"0001629137","name":"Global Blood Therapeutics, Inc.","url":"/issuer/0001629137","role":"Officer (Chief Medical Officer)","n_filings":2,"first_seen":"2015-12-23","last_seen":"2016-01-07"},{"type":"issuer","type_label":"ISSUER","cik":"0001129425","name":"ZYMOGENETICS INC","url":"/issuer/0001129425","role":"Officer (Sr. VP, Chief Medical Officer)","n_filings":1,"first_seen":"2010-02-26","last_seen":"2010-02-26"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001464907","retrieved_at":"2026-08-22T04:05:40+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}